All In MedTech

FDA Clearance Tracker · P150039

TRYTON SIDE BRANCH STENT

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Feb 21, 2017 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Feb 21, 2017

Approved

Time to decision

480 days

Received Oct 30, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P150039
Device name
TRYTON SIDE BRANCH STENT
Applicant location
Pembroke Pines, FL
Received
Oct 30, 2015
Decided
Feb 21, 2017
Decision
Approved
Supplements
5 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code MAF

FDA's approval statement

As written in FDA's record.

Approval for the TRYTON Side Branch Stent. This device is indicated for improving the side branch luminal diameter of de novo native coronary artery bifurcation lesions (Medina Classification 1.1.1; 0.1.1; 1.0.1) with a side branch diameter stenosis of >=50% and a lesion length <=5.0 mm, along with reference vessel diameters >=2.5 mm to <=3.5 mm in the side branch and >=2.5 mm to <=4.0 mm in the main branch. The device is intended for use in conjunction with commercially available balloon expandable drug-eluting coronary stents in the main branch.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MAF. The earliest in FDA's data is P910030, decided Feb 8, 1993.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Poseidon Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.